Operating expenses reached RON1.56 billion, from RON1.23 billion, hence a 27% increase.

„Despite high inflation and increased consumer costs, the Romanian company recorded in Q3 2023 a double-digit growth in most sectors of activity. Thus, the main divisions of the Group that experienced significant growth during the January – September 2023 period, compared to the same period last year, are the clinics with a 36% increase, hospitals with a 28% increase, the corporate division with a 16% increase, and laboratories with a 12% increase,” reads the company’s report.

Mihai Marcu, president and CEO of MedLife Group, says the decision to invest in oncology and hospitals, sectors less affected by economic fluctuations, underlies „our optimism that we will fully reap the rewards of our investments in the coming years. We remain steadfast in our commitment to performance and towards pacient needs, fulfilling the constant changing needs of the market”.

Regarding acquisitions, MedLife adopts a more cautious approach but acts based on current market circumstances and trends.

„The strategic priorities of the Group representatives include the upcoming inauguration of the Nord Hospital, followed by the continued development of the MedLife Park project and the opening of new medical units in the Oltenia region and the western part of the country”.

Since the start of 2023, MedLife shares have added 3%.

(English version by Catalina Apostoiu)